Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study-Reference-Cited by-同舟云学术

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Published:2017-02 Issue:2 Volume:28 Page:339-343
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Faivre S.,Niccoli P.,Castellano D.,Valle J.W.,Hammel P.,Raoul J.-L.,Vinik A.,Van Cutsem E.,Bang Y.-J.,Lee S.-H.,Borbath I.,Lombard-Bohas C.,Metrakos P.,Smith D.,Chen J.-S.,Ruszniewski P.,Seitz J.-F.,Patyna S.,Lu D.R.,Ishak K.J.,Raymond E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/2/339/13790038/mdw561.pdf

Reference21 articles.

1. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008

2. Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors;Faivre;Endocrinol Metab Clin North Am,2010

3. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis;Inoue;Cancer Cell,2002

4. SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer;Abrams;Mol Cancer Ther,2003

5. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3;Kodera;Breast Cancer Res,2011

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Management of Nonfunctional Pancreas Neuroendocrine Tumors;Surgical Clinics of North America;2024-10

2. Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours;British Journal of Surgery;2024-08-30

3. Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors;Cancers;2024-07-30

4. Multicenter validation study of a treatment selection MAP for pancreatic neuroendocrine tumors;Japanese Journal of Clinical Oncology;2024-04-27

5. Imaging of Neuroendocrine Neoplasms; Principles of Treatment Strategies. What Referring Clinicians Want to Know;Journal of Computer Assisted Tomography;2024-04-12